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Purpose of the study
To determine the contribution of transmission clusters
on transmitted drug resistance (TDR) in newly diag-
nosed antiretroviral naive patients in Northern Greece,
during 2000 -2007.
Methods
Viral reverse transcriptase and protease genes from 369
individuals with newly diagnosed HIV-1 infection were
sequenced at baseline. A maximum-likelihood phyloge-
netic analysis method was employed to examine for
linkage between viral isolates. Clinical data were
retrieved from the database and cross-referenced with
the patients’ medical files. Transmitted drug resistance
was defined in accordance with the Surveillance Drug
Resistance Mutation (SDRM) 2009 list.
Results
The study population characteristics were as follows:
82.8% male, 89.7% of Greek nationality, mean age 38,
median CD4 cell count at diagnosis 295 cells/µl and
mean HIV-1 RNA 4.94 log10 copies/ml. The most pre-
valent risk exposure category was men who have sex
with men 59.1% (n=218) followed by heterosexual
transmission 21.4% (n=79) and intravenous drug use
7.6% (n=28). Subtype B viruses were most prevalent
(53.1%), followed by subtype A (32.5%). At least one
drug resistance mutation was identified in 46/369
patients (12.4%). Twenty-eight patients (7.6%) harbored
resistance mutations to nucleoside/nucleotide RT inhi-
bitors, 20 patients (5.4%) to non-nucleoside RT inhibi-
tors and 12 patients (3.3%) to protease inhibitors (PIs).
Dual-class resistance mutations were identified in 14
patients (3.8%). The median CD4 cell count in patients
with TDR was not significantly different compared to
patients without (p=0.072). Phylogenetic analyses, sup-
ported by bootstrapping >90% and genetic distance
<0.015, revealed three transmission clusters involving
drug resistant strains, including one cluster of 11
patients infected with a strain carrying RT mutations
Y181C and T215 variants conferring NRTI and NNRTI
resistance.
Conclusions
The overall prevalence of TDR in our study population
was 12.4%. Phylogenetic analyses of viral sequences
from these new diagnoses demonstrated the impact of
transmission clusters on the primary drug resistance.
The outbreak of dual-class TDR, coupled with late HIV
diagnosis in this population may require improved pub-
lic health interventions.
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